| Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges R Butti, S Das, VP Gunasekaran, AS Yadav, D Kumar, GC Kundu Molecular cancer 17, 1-18, 2018 | 304 | 2018 |
| Breast cancer stem cells: Biology and therapeutic implications R Butti, VP Gunasekaran, TVS Kumar, P Banerjee, GC Kundu The international journal of biochemistry & cell biology 107, 38-52, 2019 | 160 | 2019 |
| MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2 A Ghosh, D Dasgupta, A Ghosh, S Roychoudhury, D Kumar, M Gorain, ... Cell death & disease 8 (3), e2706-e2706, 2017 | 155 | 2017 |
| Osteopontin as a therapeutic target for cancer M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ... Expert opinion on therapeutic targets 18 (8), 883-895, 2014 | 144 | 2014 |
| The biology and therapeutic implications of tumor dormancy and reactivation AS Yadav, PR Pandey, R Butti, NNV Radharani, S Roy, SR Bhalara, ... Frontiers in oncology 8, 72, 2018 | 57 | 2018 |
| p53 gain‐of‐function mutations increase Cdc7‐dependent replication initiation A Datta, D Ghatak, S Das, T Banerjee, A Paul, R Butti, M Gorain, ... EMBO reports 18 (11), 2030-2050, 2017 | 40 | 2017 |
| Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression R Butti, R Nimma, G Kundu, A Bulbule, TVS Kumar, VP Gunasekaran, ... Oncogene 40 (11), 2002-2017, 2021 | 37 | 2021 |
| MiRNA-146a/AKT/β-catenin activation regulates cancer stem cell phenotype in oral squamous cell carcinoma by targeting CD24 S Ghuwalewala, D Ghatak, S Das, S Roy, P Das, R Butti, M Gorain, ... Frontiers in Oncology 11, 651692, 2021 | 22* | 2021 |
| Impact of semaphorin expression on prognostic characteristics in breast cancer R Butti, TVS Kumar, R Nimma, GC Kundu Breast Cancer: Targets and Therapy, 79-88, 2018 | 20 | 2018 |
| Osteopontin Signaling in Shaping Tumor Microenvironment Conducive to Malignant Progression R Butti, TVS Kumar, R Nimma, P Banerjee, IG Kundu, GC Kundu Tumor Microenvironment, 419-441, 2021 | 14 | 2021 |
| Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula A Porwal, GC Kundu, G Bhagwat, R Butti Molecular Medicine Reports 24 (4), 1-8, 2021 | 11 | 2021 |
| Role of osteopontin in tumor microenvironment: a new paradigm in cancer therapy R Butti, P Ghosh, KVS Totakura, RNN Venkata, R Nimma, GC Kundu Multi-targeted approach to treatment of cancer, 113-125, 2015 | 11 | 2015 |
| Desialylation of sonic-hedgehog by Neu2 inhibits its association with Patched1 reducing stemness-like properties in pancreatic cancer sphere-forming cells S Nath, S Mondal, R Butti, V Prasanna Gunasekaran, U Chatterjee, ... Cells 9 (6), 1512, 2020 | 8 | 2020 |
| Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance R Butti, A Khaladkar, P Bhardwaj, G Prakasam Cancer Drug Resistance 6 (1), 182, 2023 | 6 | 2023 |
| Herbal medicine AnoSpray suppresses proinflammatory cytokines COX‑2 and RANTES in the management of hemorrhoids, acute anal fissures and perineal wounds A Porwal, GC Kundu, G Bhagwat, R Butti Experimental and Therapeutic Medicine 23 (1), 1-9, 2022 | 6 | 2022 |
| Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer model C Surve, A Banerjee, A S, R Chakraborty, D Kumar, R Butti, M Gorain, ... Nanomedicine 17 (11), 753-764, 2022 | 3 | 2022 |
| Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis G Prakasam, A Mishra, A Christie, J Miyata, D Carrillo, VT Tcheuyap, H Ye, ... The Journal of Clinical Investigation, 2024 | 1 | 2024 |
| Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer R Butti, P Kapse, G Bhadauriya, S Ahmad, R Chaubal, P Parab, R Kadam, ... Oncology Reports 49 (5), 1-10, 2023 | 1 | 2023 |
| The molecular dialogue between the tumor cells and fibroblasts R Butti, GC Kundu Oncotarget 14, 462, 2023 | | 2023 |
Dhiraj Kumar, PhDColumbia University Irving Medical Center, New York, USAVerified email at cumc.columbia.edu
